Luke Nathaniel Walker

SVP, Clinical Development, Cascadian Therapeutics, Inc.

Companies

Context Therapeutics Inc.Board member Sep 5, 2024 to now¹
Zentalis Pharmaceuticals, Inc.Board member May 29, 2024 to now²
Harpoon Therapeutics, Inc.Chief Medical Officer Oct 4, 2022 to Mar 11, 2024³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Zentalis Pharmaceuticals, Inc. ZNTL201,384 shares⁴$450.1K at $2.23Jun 16, 2026
Harpoon Therapeutics, Inc.0 shares⁵Mar 11, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 16, 2026Granted 57,100 shares of Zentalis Pharmaceuticals, Inc.⁴
Jun 17, 2025Granted 57,603 shares of Zentalis Pharmaceuticals, Inc.⁶
Jan 31, 2025Bought 14,200 shares at $1.76 of Zentalis Pharmaceuticals, Inc.⁷
May 24, 2024Granted 72,481 shares of Zentalis Pharmaceuticals, Inc.⁸
Mar 11, 2024Returned to company 135,000 shares of Harpoon Therapeutics, Inc.⁵
Jan 7, 2024Granted 115,000 shares of Harpoon Therapeutics, Inc.⁹
Nov 26, 2023Granted 20,000 shares of Harpoon Therapeutics, Inc.¹⁰

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARContext Therapeutics Inc., Board member
2
SEC EDGARZentalis Pharmaceuticals, Inc., Board member
3
SEC EDGARHarpoon Therapeutics, Inc., Chief Medical Officer
4
SEC EDGARZentalis Pharmaceuticals, Inc. shares after the filing of Jun 16, 2026
5
SEC EDGARHarpoon Therapeutics, Inc. shares after the filing of Mar 11, 2024
6
SEC EDGARForm 4 filed Jun 18, 2025
7
SEC EDGARForm 4 filed Feb 4, 2025
8
SEC EDGARForm 4 filed May 29, 2024
9
SEC EDGARForm 4 filed Jan 9, 2024
10
SEC EDGARForm 4 filed Nov 28, 2023